Evidence map›Paper›PMID 40206839›Full record

ArticleOne health (Amsterdam, Netherlands)2024

One Health investigation and response to a nationwide outbreak of Rift Valley fever in Rwanda - March to December 2022.

Leandre Ishema, Soledad Colombe, Fabrice Ndayisenga, Evodie Uwibambe, Eline Van Damme, Marie Meudec, Edson Rwagasore, Denyse Mugwaneza, Wim Van Bortel, Anselme Shyaka

Abstract read
In one paragraph

Article in One health (Amsterdam, Netherlands), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Leandre IshemaRwanda Biomedical Centre, Kigali, Rwanda.
Soledad ColombeOutbreak research team, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Fabrice NdayisengaRwanda Agriculture and Animal Resources Development Board, Kigali, Rwanda.
Evodie UwibambeRwanda Agriculture and Animal Resources Development Board, Kigali, Rwanda.
Eline Van DammeOutbreak research team, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Marie MeudecOutbreak research team, Department of Public Health, Institute of Tropical Medicine, Antwerp, Belgium.
Edson RwagasoreRwanda Biomedical Centre, Kigali, Rwanda.
Denyse MugwanezaRwanda Biomedical Centre, Kigali, Rwanda.
Wim Van BortelOutbreak research team, Department of Biomedical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Anselme ShyakaCenter for One Health, University of Global Health Equity, Butaro, Rwanda.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rift Valley fever (RVF) is an emerging zoonotic mosquito-borne disease caused by Rift Valley Fever virus (RVFV), affecting both humans and animals. It is endemic to Rwanda and Tanzania and Uganda which are adjacent countries, with possible transboundary transmissions. Despite the various outbreak reports in Rwanda since 2012, information on the intensity and spread of these outbreaks and their management is scarce. We describe the 2022 outbreak that happened in Rwanda and provide insights into the One Health response implemented during the outbreak. There were no human cases officially reported. A total of 1339 confirmed RVF animal cases were identified from 21 March until 31 December 2022. The breakdown of the cases per livestock species showed 1285 (96%) cases in cattle, 34 (3%) in goats and 20 (1%) in sheep. Of the confirmed livestock cases, 516 died and 1254 abortions were registered, in all affected species. The outbreak response was characterized by extensive interventions such as animal spraying with pyrethroid insecticides, vaccinations, and active follow-up of animals and humans in the households with animal cases. In the first phase of the outbreak, animal movements and slaughtering were restricted in the highly affected regions. Gradually, the abattoir slaughter activities were resumed with all animals required to test negative by RT-PCR before slaughter. Remarkably, the public services and hospital laboratories supported both capacity building of veterinary laboratory scientists and testing of animals' samples. The overall response was coordinated by district cross-sectoral teams linking national and community-level actors. Outbreak-related information was synthesized by the district teams and shared at national level while national strategies were communicated to the affected communities through the district structures. Rwanda's response to RVF provides a proof of concept that multisectoral efforts involving community members in a One Health approach can offer efficient response to zoonotic outbreaks while still protecting the country's economy.

Indexed as

Emerging infectious diseasesMosquitoesOne healthRift Valley feverRift Valley fever virusRwandaTransboundary animal diseasesZoonoses

Identifiers

PMID40206839
PMCPMC11980628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.